IL6 and neoplasm: The reduction in IL-5 (p < 0.05; Figure 5C), IL-6 (p < 0.01; Figure 5D), and IL-10 (p < 0.05; Figure 5E) in the tumor and spleen of the IHS-treated ApcMin/+ mice was further confirmed through ELISAs.